SUPN

28.6100.92%
KL

Kevin L. Espinoza

Chief Integrity & Compliance Officer

Mr. Kevin L. Espinoza is Chief Integrity & Compliance Officer of Supernus Pharmaceuticals, Inc. from November 2026. Mr. Espinoza is Chief Integrity & Compliance Officer of Indivior Pharmaceuticals, Inc. (formerly known as Indivior PLC) from October 2025. He served as Chief Integrity Officer of kaleo Inc. until June 2023. Mr. Espinoza served as Chief Compliance Officer at kaleo Inc. since December 2020. He is responsible for overseeing key operations at Kaleo. Mr. Espinoza joined Kaleo from Boston Scientific, where he served as the senior vice president of corporate compliance and a privacy officer. Mr. Espinoza has also served as a global RD compliance officer at Forest Laboratories, vice president and practice leader at Compliance Implementation Services, senior director and North America deputy compliance officer at GlaxoSmithKline and various roles in sales, corporate affairs and marketing at Eli Lilly. Mr. Espinoza has Bachelor's in Political Science from University of Kentucky. Mr. Espinoza has M.B.A. from West Virginia Wesleyan College.

Positions